Meditation-Based Stress Reduction in Rheumatoid Arthritis - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Meditation-Based Stress Reduction in Rheumatoid Arthritis

This study has been completed.
Information provided by National Center for Complementary and Alternative Medicine (NCCAM)

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Meditation-Based Stress Reduction in Rheumatoid Arthritis

Official Title ^†

Mindfulness Meditation-Based Stress Reduction in Relieving Symptoms Associated With Rheumatoid Arthritis

Brief Summary

The purpose of this study is to determine whether a mindfulness meditation-based stress reduction program is useful in relieving symptoms associated with rheumatoid arthritis (RA).

Detailed Description

Study Phase

Phase II

Study Type ^†

Interventional

Study Design ^†

Other, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study

Primary Outcome Measure ^†

Secondary Outcome Measure ^†

Condition ^†

Rheumatoid Arthritis

Intervention ^†

Behavioral: stress reduction program
Behavioral: meditation

MEDLINE PMIDs

7042457, 3897551, 1609875, 7649463, 8307341

Links

Related Info This link exits the ClinicalTrials.gov site

Recruitment Information Fields

Recruitment Status ^†

Completed

Enrollment ^†

Start Date ^†

July 2003

Completion Date

March 2005

Eligibility Criteria ^†

Inclusion criteria:

Confirmed diagnosis of RA, with doctor's letter or doctors' bill with ICD code 714;
18 years of age or older;
Able to read and write English;
Able to attend 15 course sessions and questionnaire sessions at Kernan Hospital in Baltimore;
Willing to practice skills for 45 minutes to 1 hour per day, 6 days a week;
Stable on rheumatoid medications for at least one month.

Exclusion criteria:

Major psychiatric illness (bipolar disorder, multiple personality disorder, etc.);
Active alcoholism or drug dependency;
Scheduled for major surgery during the study period;
Enrolled in randomized clinical trial for rheumatoid arthritis during the study period;
Planning to move out of the area in the next 12 months;
Unwilling to be enrolled in a control group;
Use of assistive device other than a cane;
Serious health condition(s) that the investigator determines would make it difficult to complete the 6 month study;
Diagnosis of fibromyalgia.

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

United States

Administrative Information Fields

NCT ID ^†

NCT00071292

Organization ID

P50 AT000084

Secondary IDs ^††

Pradhan, Elizabeth

Study Sponsor ^†

National Center for Complementary and Alternative Medicine (NCCAM)

Collaborators ^††

Investigators ^†

Principal Investigator:

Brian Berman, MD

Director, Center for Integrative Medicine

Information Provided By

National Center for Complementary and Alternative Medicine (NCCAM)

Verification Date

March 2008

First Received Date ^†

October 17, 2003

Last Updated Date

March 5, 2008

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.